Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 13/20 | 0.66 |
| ▸ | PPARA | Q07869 | 4/20 | 0.60 |
| ▸ | PPARG | P37231 | 4/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.54 |
| ▸ | PTGES | O14684 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20634811 | 0.91 | ALOX5 (0.63) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL20636309 | 0.88 | ALOX5 (0.55) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL2290607 | 0.82 | PPARA (0.68) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL2290611 | 0.82 | PPARA (0.68) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL2290615 | 0.82 | PPARA (0.68) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL20636230 | 0.81 | ALOX5 (0.54) | ALOX5 | |
| SCHEMBL16077002 | 0.81 | PPARA (0.81) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL16136832 | 0.81 | PPARA (0.69) | ALOX5PPARAPPARGNR1I2PTGES | |
| SCHEMBL20634812 | 0.81 | ALOX5 (0.48) | ALOX5PPARAPPARGNR1I2 | |
| SCHEMBL26188784 | 0.80 | PPARA (0.66) | ALOX5PPARAPPARGNR1I2PTGES |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2023-01-26 | — | — | US | disclosed |
| US-11400160-B2 | Multifunctional conjugates | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2022-08-02 | — | — | US | disclosed |
| US-20200164076-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2020-05-28 | — | — | US | disclosed |
| WO-2019007447-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2019-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | ALOX5 1402/4885PPARA 1122/4885PPARG 621/4885 |
| US-20200164076-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | ALOX5 1462/4885PPARA 1219/4885PPARG 642/4885 |
| US-11400160-B2 | Multifunctional conjugates | MKI67, ACP3, CD44 | ALOX5 1462/4885PPARA 1219/4885PPARG 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.